EMA Authorised: Plavix (clopidogrel hydrogen sulfate) — Sanofi Winthrop Industrie

View source ↗

Summary

The EMA authorised Plavix (clopidogrel hydrogen sulfate) for use with indications including stroke, peripheral vascular disease, atrial fibrillation, myocardial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Syndrome
• Myocardial Infarction
• Peripheral Vascular Disease
• Stroke

Drugs mentioned

• Plavix (clopidogrel)

Snippet

Status: Authorised. Therapeutic area: Stroke;Peripheral Vascular Diseases;Atrial Fibrillation;Myocardial Infarction;Acute Coronary Syndrome. MAH: Sanofi Winthrop Industrie. Decision date: 11/07/2025